Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SXTP 60 Degrees Pharmaceuticals, Inc. Common Stock
$0.86 -1.17% -0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SXTP stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

Loading

Key Stats

Market cap. 3.0M
Enterprise value 11.7M
Trailing PE 14.714285
Forward PE -0.2430447
PEG Ratio -0.1794425
Enterprise to EBITDA -1.372
Enterprise to revenue 9.606
Price to book MRQ 0.88985600033364
Price to sales TTM 2.5187693

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.2M
EBITDA -8504303
Diluted EPS TTM -5.25
Total Cash (MRQ) 1.0M
Current ratio (MRQ) 2.325
Operating Cash Flow (TTM) -8774808

SXTP trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SXTP News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.